Expedition Therapeutics Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$115M
- Investors
-
14
Expedition Therapeutics General Information
Description
Developer of biotechnology therapies designed to treat serious inflammatory and respiratory diseases. The company offers novel therapeutic candidates for inflammatory and respiratory conditions, enabling healthcare professionals to access treatment options for patients with serious diseases.
Contact Information
Website
www.expeditiontx.comCorporate Office
- 2261 Market Street
- Suite 10321
- San Francisco, CA 94114
- United States
Corporate Office
- 2261 Market Street
- Suite 10321
- San Francisco, CA 94114
- United States
Expedition Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series B) | 05-Aug-2026 | $115M | Completed | Clinical Trials - Phase 2 | ||
| 1. Early Stage VC (Series A) | Completed | Clinical Trials - Phase 1 |
Expedition Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A2 | ||||||||
| Series A1 | 44,424,088 | $0.000010 | 8% | $3.71 | $3.71 | 1x | $3.71 | 55.01% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Expedition Therapeutics Signals
Expedition Therapeutics Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Adage Capital Management | Hedge Fund | Minority | ||
| Balyasny Asset Management | Hedge Fund | Minority | ||
| BVF Partners | Hedge Fund | Minority | ||
| Dawn Biopharma | Corporation | Minority | ||
| Forbion | Venture Capital | Minority |
Expedition Therapeutics FAQs
-
When was Expedition Therapeutics founded?
Expedition Therapeutics was founded in 2024.
-
Where is Expedition Therapeutics headquartered?
Expedition Therapeutics is headquartered in San Francisco, CA.
-
What is the size of Expedition Therapeutics?
Expedition Therapeutics has 3 total employees.
-
What industry is Expedition Therapeutics in?
Expedition Therapeutics’s primary industry is Biotechnology.
-
Is Expedition Therapeutics a private or public company?
Expedition Therapeutics is a Private company.
-
What is the current valuation of Expedition Therapeutics?
The current valuation of Expedition Therapeutics is .
-
What is Expedition Therapeutics’s current revenue?
The current revenue for Expedition Therapeutics is .
-
How much funding has Expedition Therapeutics raised over time?
Expedition Therapeutics has raised $280M.
-
Who are Expedition Therapeutics’s investors?
Adage Capital Management, Balyasny Asset Management, BVF Partners, Dawn Biopharma, and Forbion are 5 of 14 investors who have invested in Expedition Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process